A Preliminary Controlled Trial of Cognitive Behavioral Therapy in Clozapine-Resistant Schizophrenia

The use of cognitive-behavior therapy (CBT) in addition to antipsychotic regimen to treat persistent psychotic symptoms of schizophrenia is growing. The aim of this study was to compare the efficacy of CBT to a befriending (BF) control group in patients with schizophrenia who are refractory to cloza...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of nervous and mental disease 2009-11, Vol.197 (11), p.865-868
Hauptverfasser: de Paiva Barretto, Eliza Martha, Kayo, Monica, Avrichir, Belquiz S, Sa, Antonio Reis, Camargo, Maria das Gracas Miquelutti, Napolitano, Isabel Cristina, Nery, Fabiano Gonçalves, Pinto, Jony Arrais, Bannwart, Silvia, Scemes, Silvia, Di Sarno, Elaine, Elkis, Helio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The use of cognitive-behavior therapy (CBT) in addition to antipsychotic regimen to treat persistent psychotic symptoms of schizophrenia is growing. The aim of this study was to compare the efficacy of CBT to a befriending (BF) control group in patients with schizophrenia who are refractory to clozapine. Twenty-one patients completed the 21-week trial. In comparison with the control group, the CBT group showed a significant improvement in the General Psychopathology and total score of the Positive and Negative Syndrome Scale, as well as an improvement of Quality of Life scale. The improvement in psychopathology persisted at 6-month follow-up assessment.
ISSN:0022-3018
1539-736X
DOI:10.1097/NMD.0b013e3181be7422